Stay updated on Belantamab Mafodotin in Myeloma Clinical Trial
Sign up to get notified when there's something new on the Belantamab Mafodotin in Myeloma Clinical Trial page.

Latest updates to the Belantamab Mafodotin in Myeloma Clinical Trial page
- Check6 days agoChange DetectedA new revision entry v3.6.3 was added to the Study Record Versions and the previous revision v3.6.2 was removed from the history.SummaryDifference0.1%

- Check13 days agoChange DetectedAn additional revision entry v3.6.2 was added to the study record history, and the previous v3.6.0 entry was removed. This reflects a version update for the page's backend/UI.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check28 days agoChange DetectedEnrollment is no longer open for the study, indicating recruitment has ended. The history now shows a new version label, v3.6.0, replacing the prior v3.5.5.SummaryDifference0.4%

- Check35 days agoChange DetectedThe history now includes a new revision entry for v3.5.5, replacing the previous v3.5.4. This represents a software release update to the page history.SummaryDifference0.1%

- Check56 days agoChange DetectedAdded a new revision entry 'Revision: v3.5.4' to the study record history and removed the previous 'Revision: v3.5.3' entry. The version history now reflects the latest revision of the record.SummaryDifference0.1%

- Check77 days agoChange DetectedThe web interface’s revision version indicator has been updated from v3.5.2 to v3.5.3, reflecting a site release rather than a change to the underlying ClinicalTrials.gov record details.SummaryDifference0.1%

Stay in the know with updates to Belantamab Mafodotin in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Belantamab Mafodotin in Myeloma Clinical Trial page.